These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 10189977

  • 1. Fluoxetine versus placebo for the marijuana use of depressed alcoholics.
    Cornelius JR, Salloum IM, Haskett RF, Ehler JG, Jarrett PJ, Thase ME, Perel JM.
    Addict Behav; 1999; 24(1):111-4. PubMed ID: 10189977
    [Abstract] [Full Text] [Related]

  • 2. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR, Salloum IM, Thase ME, Haskett RF, Daley DC, Jones-Barlock A, Upsher C, Perel JM.
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [Abstract] [Full Text] [Related]

  • 3. Double-blind fluoxetine in depressed alcoholic smokers.
    Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Black A, Perel JM, Thase ME.
    Psychopharmacol Bull; 1997; 33(1):165-70. PubMed ID: 9133770
    [Abstract] [Full Text] [Related]

  • 4. Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial.
    Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Perel JM, Thase ME, Black A.
    Arch Gen Psychiatry; 1997 Aug; 54(8):700-5. PubMed ID: 9283504
    [Abstract] [Full Text] [Related]

  • 5. Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study.
    Cornelius JR, Salloum IM, Haskett RF, Daley DC, Cornelius MD, Thase ME, Perel JM.
    Addict Behav; 2000 Aug; 25(2):307-10. PubMed ID: 10795957
    [Abstract] [Full Text] [Related]

  • 6. Preliminary report: double-blind, placebo-controlled study of fluoxetine in depressed alcoholics.
    Cornelius JR, Salloum IM, Cornelius MD, Perel JM, Ehler JG, Jarrett PJ, Levin RL, Black A, Mann JJ.
    Psychopharmacol Bull; 1995 Aug; 31(2):297-303. PubMed ID: 7491382
    [Abstract] [Full Text] [Related]

  • 7. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.
    Vercoulen JH, Swanink CM, Zitman FG, Vreden SG, Hoofs MP, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G.
    Lancet; 1996 Mar 30; 347(9005):858-61. PubMed ID: 8622391
    [Abstract] [Full Text] [Related]

  • 8. Fluoxetine versus placebo to decrease the smoking of depressed alcoholic patients.
    Cornelius JR, Perkins KA, Salloum IM, Thase ME, Moss HB.
    J Clin Psychopharmacol; 1999 Apr 30; 19(2):183-4. PubMed ID: 10211921
    [No Abstract] [Full Text] [Related]

  • 9. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
    Gillin JC, Rapaport M, Erman MK, Winokur A, Albala BJ.
    J Clin Psychiatry; 1997 May 30; 58(5):185-92. PubMed ID: 9184611
    [Abstract] [Full Text] [Related]

  • 10. Fluoxetine trial in suicidal depressed alcoholics.
    Cornelius JR, Salloum IM, Cornelius MD, Perel JM, Thase ME, Ehler JG, Mann JJ.
    Psychopharmacol Bull; 1993 May 30; 29(2):195-9. PubMed ID: 8290665
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P, Baker B, Irvine J, Dorian P, McKessok D, Mendlowitz S.
    Depress Anxiety; 1998 May 30; 7(2):69-72. PubMed ID: 9614594
    [Abstract] [Full Text] [Related]

  • 12. Is metabolic dysregulation associated with antidepressant response in depressed women in climacteric treated with individualized homeopathic medicines or fluoxetine? The HOMDEP-MENOP Study.
    Macías-Cortés ED, Llanes-González L, Aguilar-Faisal L, Asbun-Bojalil J.
    Homeopathy; 2017 Feb 30; 106(1):3-10. PubMed ID: 28325221
    [Abstract] [Full Text] [Related]

  • 13. Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.
    Cornelius JR, Bukstein OG, Douaihy AB, Clark DB, Chung TA, Daley DC, Wood DS, Brown SJ.
    Drug Alcohol Depend; 2010 Nov 01; 112(1-2):39-45. PubMed ID: 20576364
    [Abstract] [Full Text] [Related]

  • 14. Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders.
    Hirschtritt ME, Pagano ME, Christian KM, McNamara NK, Stansbrey RJ, Lingler J, Faber JE, Demeter CA, Bedoya D, Findling RL.
    J Subst Abuse Treat; 2012 Jun 01; 42(4):366-72. PubMed ID: 22116008
    [Abstract] [Full Text] [Related]

  • 15. Clinician, parent, and child prediction of medication or placebo in double-blind depression study.
    Hughes CW, Emslie G, Kowatch R, Weinberg W, Rintelmann J, Rush AJ.
    Neuropsychopharmacology; 2000 Nov 01; 23(5):591-4. PubMed ID: 11027925
    [Abstract] [Full Text] [Related]

  • 16. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.
    J Clin Psychiatry; 2009 Oct 01; 70(10):1424-31. PubMed ID: 19906346
    [Abstract] [Full Text] [Related]

  • 17. Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
    Lapierre YD, Joffe R, McKenna K, Bland R, Kennedy S, Ingram P, Reesal R, Rickhi BG, Beauclair L, Chouinard G, Annable L.
    J Psychiatry Neurosci; 1997 Mar 01; 22(2):118-26. PubMed ID: 9074306
    [Abstract] [Full Text] [Related]

  • 18. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.
    Silverstone PH, Ravindran A.
    J Clin Psychiatry; 1999 Jan 01; 60(1):22-8. PubMed ID: 10074873
    [Abstract] [Full Text] [Related]

  • 19. Impact of physical illness on quality of life and antidepressant response in geriatric major depression. Fluoxetine Collaborative Study Group.
    Small GW, Birkett M, Meyers BS, Koran LM, Bystritsky A, Nemeroff CB.
    J Am Geriatr Soc; 1996 Oct 01; 44(10):1220-5. PubMed ID: 8856002
    [Abstract] [Full Text] [Related]

  • 20. Placebo-controlled treatment trial of depression in elderly physically ill patients.
    Evans M, Hammond M, Wilson K, Lye M, Copeland J.
    Int J Geriatr Psychiatry; 1997 Aug 01; 12(8):817-24. PubMed ID: 9283926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.